<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04796935</url>
  </required_header>
  <id_info>
    <org_study_id>INT-001</org_study_id>
    <nct_id>NCT04796935</nct_id>
  </id_info>
  <brief_title>A Study to Test Performance of Needle Placements for Neuraxial Procedures Using Tactile Imaging vs Control</brief_title>
  <official_title>An Open-Label, Parallel, Randomized Study to Evaluate the Performance of Needle Placements for Diagnostic and Therapeutic Neuraxial Procedures, Using a Handheld Tactile Imaging-based Method Versus Palpation</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>IntuiTap Medical, Inc</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>ICON plc</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>IntuiTap Medical, Inc</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_unapproved_device>Yes</is_unapproved_device>
    <is_us_export>Yes</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study will compare the VerTouch device the conventional palpation technique for&#xD;
      performing diagnostic and therapeutic neuraxial procedures.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Neuraxial procedures, in which a needle is inserted into the spinal canal through a gap in&#xD;
      the vertebrae, are performed at a rate of nearly 13 million per year in the US, across a&#xD;
      myriad of diagnostic and therapeutic clinical scenarios.&#xD;
&#xD;
      The standard of care involves manual palpation of the patient's back to detect the spinous&#xD;
      processes (SPs) and estimate the location of the interspinous needle insertion site. While&#xD;
      providers are trained to perform these procedures with meticulous precision and attention to&#xD;
      detail, this technique remains highly inaccurate, often requiring multiple insertion attempts&#xD;
      to properly place the needle. These attempts lead to patient pain and complications, such as&#xD;
      traumatic taps and PDPHs; unpredictable procedure times; and poor facility throughput.&#xD;
&#xD;
      The VerTouch device uses tactile imaging to offer a non-invasive, untethered, non&#xD;
      radiation-producing solution for visualizing spinal anatomy in order to identify an ideal&#xD;
      location for needle placement in a neuraxial procedure. The device can be used to mark the&#xD;
      identified site with a surgical marker, or to begin placement of a needle or introducer at&#xD;
      that site.&#xD;
&#xD;
      Study participants will be recruited in two parallel cohorts: the control (palpation) group&#xD;
      or the tactile imaging (VerTouch) group, further stratified by procedure setting, including&#xD;
      emergency medicine, neurology, and anesthesiology. Once an insertion site is marked with a&#xD;
      marker or shallow placement of a needle or introducer, the procedure will continue in the&#xD;
      usual manner for subjects in both groups.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">April 4, 2021</start_date>
  <completion_date type="Anticipated">November 9, 2021</completion_date>
  <primary_completion_date type="Anticipated">August 31, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>An open-label, parallel, randomized study design</intervention_model_description>
    <primary_purpose>Other</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Number of insertion attempts</measure>
    <time_frame>End of procedure</time_frame>
    <description>Any forward movement of the needle following puncture of the skin, counted until confirmation of spinal canal access can be assessed.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Incidence of first-insertion success</measure>
    <time_frame>End of procedure</time_frame>
    <description>A case that does not require any reinsertions, but can include any number of redirections.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of redirections</measure>
    <time_frame>End of procedure</time_frame>
    <description>Any forward movement of the needle in a new direction not preceded by withdrawal from the skin, counted until confirmation of spinal canal access can be assessed.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of passes</measure>
    <time_frame>End of procedure</time_frame>
    <description>Any forward movement of the needle, calculated as the sum of insertions and redirections.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Incidence of first-pass success</measure>
    <time_frame>End of procedure</time_frame>
    <description>A case that does not require reinsertions or redirections.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Subject discomfort during landmarking</measure>
    <time_frame>End of procedure</time_frame>
    <description>Evaluated using a 10-point Numeric Pain Rating Scale, where 1 is equivalent to no pain and 10 is equivalent to the worst possible pain.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Provider confidence with the identified insertion site</measure>
    <time_frame>End of procedure</time_frame>
    <description>Evaluated using a 1-5 point Numeric Rating Scale where 1 is equivalent to not at all confident and 5 equivalent to completely confident.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">96</enrollment>
  <condition>Central Nervous System Infections</condition>
  <condition>Pseudotumor Cerebri</condition>
  <condition>Neurological Disorder</condition>
  <condition>Cancer</condition>
  <condition>Obstetric Procedure Pain</condition>
  <condition>Orthopedic Procedure Pain</condition>
  <condition>Post-Dural Puncture Headache</condition>
  <arm_group>
    <arm_group_label>Experimental Group 1: Tactile Imaging (VerTouch)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>VerTouch used to identify and mark, or begin placement of a needle, at an insertion site.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group 2: Control (palpation)</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Palpation used to identify and mark an insertion site.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Device Group 1: Tactile Imaging (VerTouch)</intervention_name>
    <description>VerTouch device used to identify and mark, or begin placement of a needle at an insertion site. After the device is taken off the back, the procedure will continue in the usual manner for subjects in both groups.</description>
    <arm_group_label>Experimental Group 1: Tactile Imaging (VerTouch)</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Group 2: Control (palpation)</intervention_name>
    <description>Control, palpation used to identify and mark an insertion site.</description>
    <arm_group_label>Group 2: Control (palpation)</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. Males and females aged 18 years and above, inclusive&#xD;
&#xD;
          2. Subjects scheduled for one of the following procedures:&#xD;
&#xD;
               -  Diagnostic LP (collection of CSF and/or measurement of ICP to diagnose&#xD;
                  hemorrhaging or neurological infections)&#xD;
&#xD;
               -  Therapeutic LP (intrathecal injection of therapeutic agents; drainage of CSF to&#xD;
                  treat pseudotumor cerebri)&#xD;
&#xD;
               -  Planned orthopedic or obstetric procedure, such as labor/induction, cesarean&#xD;
                  section, hysterectomy, or total hip/knee replacement, with neuraxial anesthesia&#xD;
                  (injection of anesthetic into spinal and/or epidural space to reduce pain during&#xD;
                  procedure)&#xD;
&#xD;
               -  Epidural blood patch (use of autologous blood to close holes in the dura mater&#xD;
                  and relieve PDPH)&#xD;
&#xD;
          3. Subjects having a BMI â‰¤42kg/m2&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Patient does not provide informed consent&#xD;
&#xD;
          2. Skin or soft tissue infection near the puncture site&#xD;
&#xD;
          3. Allergy to local anesthetic&#xD;
&#xD;
          4. Uncorrected coagulopathy&#xD;
&#xD;
          5. Acute spinal cord trauma&#xD;
&#xD;
          6. History of lumbar spinal surgery&#xD;
&#xD;
          7. Prior known failed neuraxial anesthesia&#xD;
&#xD;
          8. Diagnosed scoliosis, thoracic kyphosis, lumbar lordosis, scleroderma, or ankylosing&#xD;
             spondylitis, or lumbar spinal stenosis&#xD;
&#xD;
          9. Incarcerated subjects&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Nicole C Moskowitz</last_name>
    <phone>845-729-0101</phone>
    <email>ncmoskowitz@intuitapmedical.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Geoff Hutchins</last_name>
    <phone>312-560-4138</phone>
    <email>ghutchins@intuitapmedical.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Rhode Island Hospital</name>
      <address>
        <city>Providence</city>
        <state>Rhode Island</state>
        <zip>02903</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Francesca Beaudoin, MD, PhD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>University of Texas Health Science Center</name>
      <address>
        <city>Houston</city>
        <state>Texas</state>
        <zip>77030</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Rohini Samudralwar, MD</last_name>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>August 2021</verification_date>
  <study_first_submitted>March 10, 2021</study_first_submitted>
  <study_first_submitted_qc>March 10, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">March 15, 2021</study_first_posted>
  <last_update_submitted>August 3, 2021</last_update_submitted>
  <last_update_submitted_qc>August 3, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">August 5, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Diagnostic spinal puncture</keyword>
  <keyword>Therapeutic spinal puncture</keyword>
  <keyword>Lumbar puncture</keyword>
  <keyword>Epidural</keyword>
  <keyword>Neuraxial anesthesia</keyword>
  <keyword>Blood patch</keyword>
  <keyword>ESI</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Central Nervous System Infections</mesh_term>
    <mesh_term>Nervous System Diseases</mesh_term>
    <mesh_term>Post-Dural Puncture Headache</mesh_term>
    <mesh_term>Pseudotumor Cerebri</mesh_term>
    <mesh_term>Headache</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

